Atlas Trials

PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy

Clinical trial NCT07443696 · RECRUITING

Trial details

NCT number
NCT07443696
Sponsor
Sinotau Pharmaceutical Group
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ischemic CardiomyopathyHeart Failure
Start date
2025-12-18
Primary completion
2026-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.